Last week, researchers at Johns Hopkins released the results of a cohort study measuring the antibody production of 436 solid organ transplant recipients following their first dose of an mRNA vaccine. Immunocompromised patients were excluded from mRNA clinical trials.
Read More »The J&J COVID vaccine received emergency use authorization (EUA) by the FDA this past weekend. This single-shot vaccine is the third COVID vaccine to be released in the United States, with plans to deliver 16 million doses to the federal government by the end of March. Due to production issues, this will be significantly less than the 37 million dose figure released by J&J while recommendation by the FDA was still under review. The first 3.9 million doses, created in J&J’s Netherland factory, are expected to arrive in America by today, March 2.
Read More »The B.1.1.7 coronavirus variant was first identified in the UK this past fall, emerging in Colorado soon thereafter. According to the CDC, there have been upwards of 1,000 cases caused by the B.1.1.7 variant across 34 states as of February 9, 2021. California and Florida, two states that have taken vastly different approaches for containing the novel coronavirus, have both reported the highest numbers of B.1.1.7 cases.
Read More »In a live video update on February 3, 2021, Dr. Anthony Fauci, Director of NIAID, spoke with Dr. Howard Bauchner, editor and chief from the JAMA Network, about the status of the coronavirus pandemic in the U.S. Dr. Fauci started off by explaining that our current challenge with regard to vaccines is the issue of variants. While the overall efficacy of the vaccine is diminished with variants, it can still reduce severe cases of COVID-19. This is good news; however, we do still have to pay attention when it comes to the spread of variants.
Read More »